8-Bromo-2-chloroquinazolin-4-amine

Catalog No. :
ACJQOB403
CAS No. :
956100-62-2
Molecular Formula :
C8H5BrClN3
Molecular Weight :
258.51

IUPAC Name:8-bromo-2-chloroquinazolin-4-amine

8-Bromo-2-chloroquinazolin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$60.00Login to see priceIn stockIn stock
25g98%$222.00Login to see priceIn stockIn stock
100g98%$717.00Login to see priceIn stockInquiry
500g98%$3477.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Bromo-2-chloroquinazolin-4-amine
IUPAC Name8-bromo-2-chloroquinazolin-4-amine
MDL No.MFCD11858275
Molecular FormulaC8H5BrClN3
Molecular Weight258.51
SMILESNC1=C2C=CC=C(Br)C2=NC(Cl)=N1
InChI KeyFRWKIQGVGJPSFF-UHFFFAOYSA-N
Synonym8-bromo-2-chloroquinazolin-4-amine | 956100-62-2 | 4-Amino-8-bromo-2-chloroquinazoline | 2-Chloro-4-Amino-8-Bromoquinazoline | SCHEMBL558306 | DTXSID30549437 | FRWKIQGVGJPSFF-UHFFFAOYSA-N | MFCD11858275 | AKOS015834730 | CS-W006651 | GS-4342 | SB74063 | FT-0714777 | EN300-3098584 |
CAS No.956100-62-2
PubChem CID13785877

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJQOB403 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLVWU240 route compound structure diagram
    ACLVWU240331647-05-3 In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACJQOB403 route product structure diagram
    ACJQOB403956100-62-2 In Stock
Inquiry

2. ACJQOB403 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLVWU240 route compound structure diagram
    ACLVWU240331647-05-3 In Stock
  2. Then
  3. ACJQOB403 route product structure diagram
    ACJQOB403956100-62-2 In Stock
Inquiry

Comments (0)